SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $22,000 | -74.4% | 1,046 | -71.3% | 0.00% | -80.0% |
| Q2 2020 | $86,000 | -72.1% | 3,642 | -60.8% | 0.01% | -66.7% |
| Q2 2019 | $308,000 | +11.2% | 9,300 | +17.7% | 0.02% | -6.2% |
| Q1 2019 | $277,000 | +182.7% | 7,900 | +168.0% | 0.02% | +128.6% |
| Q4 2018 | $98,000 | -91.4% | 2,948 | -86.9% | 0.01% | -89.4% |
| Q3 2018 | $1,133,000 | +92.0% | 22,500 | +128.2% | 0.07% | +78.4% |
| Q2 2018 | $590,000 | +34.7% | 9,860 | +3.0% | 0.04% | +15.6% |
| Q1 2018 | $438,000 | +25.1% | 9,574 | +9.1% | 0.03% | +14.3% |
| Q4 2017 | $350,000 | +35.1% | 8,774 | +35.4% | 0.03% | +21.7% |
| Q3 2017 | $259,000 | -7.2% | 6,478 | 0.0% | 0.02% | -11.5% |
| Q2 2017 | $279,000 | -6.7% | 6,478 | -32.1% | 0.03% | -10.3% |
| Q1 2017 | $299,000 | +68.0% | 9,545 | +35.3% | 0.03% | +31.8% |
| Q4 2016 | $178,000 | -52.0% | 7,057 | -52.9% | 0.02% | -43.6% |
| Q3 2016 | $371,000 | +50.8% | 14,998 | +24.1% | 0.04% | +14.7% |
| Q2 2016 | $246,000 | -19.1% | 12,081 | -39.4% | 0.03% | -19.0% |
| Q1 2016 | $304,000 | +114.1% | 19,927 | +88.0% | 0.04% | +90.9% |
| Q4 2015 | $142,000 | +195.8% | 10,600 | +211.8% | 0.02% | +214.3% |
| Q3 2015 | $48,000 | -23.8% | 3,400 | -8.1% | 0.01% | -22.2% |
| Q2 2015 | $63,000 | -10.0% | 3,700 | -36.2% | 0.01% | -10.0% |
| Q1 2015 | $70,000 | -58.1% | 5,800 | -71.1% | 0.01% | -58.3% |
| Q4 2014 | $167,000 | – | 20,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |